Dipartimento delle Scienze Biologiche, Università di Napoli Federico II, Napoli, Italia.
PLoS One. 2012;7(12):e52040. doi: 10.1371/journal.pone.0052040. Epub 2012 Dec 18.
Improved diagnosis of psoriasis, by new biomarkers, is required for evaluating the progression rate of the disease and the response to treatment. Haptoglobin (Hpt), a glycoprotein secreted by hepatocytes and other types of cells including keratinocytes, was found with glycan changes in psoriasis and other diseases. We previously reported that Hpt isolated from plasma of psoriatic patients is more fucosylated than Hpt of healthy subjects. The aim of this study was to compare the glycosylation pattern of Hpt isolated from skin scales or plasma of patients with psoriasis with that of Hpt from cornified epidermal layer or plasma of healthy subjects. High performance liquid chromatography analysis of the glycans isolated from the protein backbone revealed that glycan patterns from skin and plasma of patients were similar, and mostly displayed quantitative rather than qualitative differences from normal pattern. Biotin-labeled lectins were used to evaluate quantitative differences in the glycoforms of Hpt from plasma and psoriatic skin scales. Hpt from skin and plasma of patients showed more fucosylated and branched glycans than Hpt from plasma of healthy subjects. Tryptic glycopeptides of Hpt were also analyzed by mass spectrometry, and a decreased amount of sialylated glycan chains was found in glycopeptides of skin Hpt, as compared with Hpt from plasma. High levels of glycans with fucosylated and tetra-antennary chains were detected on the peptide NLFLNHSENATAK from Hpt of psoriatic patients. Our data demonstrate that specific changes in glycan structures of Hpt, such as enhanced glycan branching and fucose content, are associated with psoriasis, and that differences between circulating and skin Hpt do exist. A lower extent of glycan fucosylation and branching was found in Hpt from plasma of patients in disease remission. Altered glycoforms might reflect changes of Hpt function in the skin, and could be used as markers of the disease.
需要新的生物标志物来改善银屑病的诊断,以评估疾病的进展速度和治疗反应。触珠蛋白(Haptoglobin,Hpt)是一种由肝细胞和包括角质形成细胞在内的其他类型细胞分泌的糖蛋白,在银屑病和其他疾病中发现其糖基化发生改变。我们之前的研究报告称,从银屑病患者血浆中分离的 Hpt 比健康受试者的 Hpt 更岩藻糖化。本研究的目的是比较从银屑病患者皮肤鳞屑或血浆中分离的 Hpt 与从健康受试者角化细胞层或血浆中分离的 Hpt 的糖基化模式。从蛋白质主链分离的聚糖的高效液相色谱分析表明,来自皮肤和患者血浆的聚糖模式相似,并且主要显示出与正常模式的定量而非定性差异。生物素标记的凝集素用于评估来自血浆和银屑病皮肤鳞屑的 Hpt 糖型的定量差异。来自皮肤和患者血浆的 Hpt 比来自健康受试者血浆的 Hpt 显示出更多的岩藻糖化和支化聚糖。还通过质谱法分析了 Hpt 的胰蛋白酶糖肽,与来自血浆的 Hpt 相比,皮肤 Hpt 的唾液酸化糖链数量减少。在来自银屑病患者的 Hpt 的肽 NLFLNHSENATAK 上检测到高含量的具有岩藻糖化和四触角链的聚糖。我们的数据表明,Hpt 糖基结构的特定变化,如增强的糖基支化和岩藻糖含量,与银屑病有关,并且循环和皮肤 Hpt 之间确实存在差异。在疾病缓解的患者血浆 Hpt 中发现糖基化和支化程度较低。糖型的改变可能反映了 Hpt 在皮肤中的功能变化,并且可以用作疾病的标志物。